We are live on
!
Find out more
GA
Gagnon Advisors Portfolio holdings
AUM
$136M
1-Year Est. Return
21.55%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$154M
AUM Growth
-$10.7M
(-6.5%)
Cap. Flow
-$5.58M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
54.87%
Holding
34
New
1
Increased
8
Reduced
11
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZUO
Zuora, Inc.
ZUO
|
+$3.58M |
| 2 |
Heron Therapeutics
HRTX
|
+$2.25M |
| 3 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$2.16M |
| 4 |
ETWO
E2open Parent Holdings
ETWO
|
+$1.76M |
| 5 |
Freshworks
FRSH
|
+$1.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
|
+$4.67M |
| 2 |
Pacira BioSciences
PCRX
|
+$3.06M |
| 3 |
Ameresco
AMRC
|
+$1.84M |
| 4 |
Celcuity
CELC
|
+$1.65M |
| 5 |
Navigator Holdings
NVGS
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Healthcare | 25.84% |
| 3 | Industrials | 17.88% |
| 4 | Energy | 12.89% |
| 5 | Real Estate | 2.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Navigator Holdings
NVGS
$1.37B
| $10.4M | 6.73% |
907,548
-122,767
| -12% | -$1.4M |
|
|
2
Ameresco
AMRC
$1.09B
| $9.66M | 6.25% |
145,260
-30,000
| -17% | -$1.84M |
|
|
3
Pacira BioSciences
PCRX
$1.06B
| $9.59M | 6.21% |
180,331
-55,114
| -23% | -$3.06M |
|
4
Enterprise Products Partners
EPD
$82.5B
| $9.51M | 6.16% |
399,855
| – | – |
|
|
EVA
5
DELISTED
Enviva Inc.
EVA
| $8.66M | 5.61% |
144,140
-10,115
| -7% | -$680K |
|
|
AL
6
DELISTED
Air Lease Corp
AL
| $8.18M | 5.3% |
263,700
-33,501
| -11% | -$1.2M |
|
|
NEWR
7
DELISTED
New Relic, Inc.
NEWR
| $7.86M | 5.09% |
137,048
| – | – |
|
|
APEN
8
DELISTED
Apollo Endosurgery, Inc.
APEN
| $7.33M | 4.74% |
1,329,354
| – | – |
|
9
BioLife Solutions
BLFS
$1.55B
| $6.94M | 4.49% |
304,910
| – | – |
|
|
ETWO
10
DELISTED
E2open Parent Holdings
ETWO
| $6.63M | 4.29% |
1,092,450
+251,503
| +30% | +$1.76M |
|
11
BlackLine
BL
$1.8B
| $6.56M | 4.25% |
109,483
-14,360
| -12% | -$963K |
|
|
ZUO
12
DELISTED
Zuora, Inc.
ZUO
| $6.13M | 3.97% |
831,074
+415,537
| +100% | +$3.58M |
|
13
Yext
YEXT
$552M
| $5.97M | 3.86% |
1,338,026
-286,968
| -18% | -$1.33M |
|
14
FIVE9
FIVN
$2.12B
| $5.93M | 3.84% |
79,043
-10,350
| -12% | -$1.01M |
|
15
CareDx
CDNA
$1.97B
| $5.72M | 3.7% |
336,104
+58,757
| +21% | +$1.26M |
|
16
Alpha and Omega Semiconductor
AOSL
$931M
| $5.46M | 3.54% |
177,557
| – | – |
|
|
SCWX
17
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $4.75M | 3.08% |
590,730
| – | – |
|
18
Equinix
EQIX
$103B
| $3.9M | 2.53% |
6,861
| – | – |
|
|
EVBG
19
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $3.22M | 2.09% |
104,383
| – | – |
|
|
20
Freshworks
FRSH
$3.11B
| $3.07M | 1.99% |
236,518
+117,941
| +99% | +$1.67M |
|
|
SLGC
21
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $2.98M | 1.93% |
1,025,936
+512,968
| +100% | +$2.16M |
|
|
PROF
22
Profound Medical
PROF
$263M
| $2.62M | 1.7% |
648,465
+207,409
| +47% | +$1.4M |
|
|
23
Heron Therapeutics
HRTX
$94.1M
| $2.43M | 1.57% |
+576,206
| New | +$2.25M |
|
|
LL
24
DELISTED
LL Flooring Holdings, Inc.
LL
| $2.13M | 1.38% |
307,506
-102,250
| -25% | -$919K |
|
|
CNF
25
CNFinance Holdings
CNF
$37.1M
| $1.98M | 1.28% |
78,472
| – | – |
|
Similar funds
WF
MWA
SSCM
BDCMI
WA
LCM
NVCHI
GPWA
Gagnon Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Gagnon Advisors held 34 positions worth $154M, down 6.5% from $165M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Gagnon Advisors withdrew a net $5.58M in Q3 2022, closing 2 positions and reducing 11 holdings. Its most notable exit was Direxion Daily 20+ Year Treasury Bear 3X ETF, an estimated $4.67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Gagnon Advisors opened a new position in Heron Therapeutics worth $2.43M.
- Gagnon Advisors's largest Q3 2022 buy was Heron Therapeutics: 576,206 shares worth $2.43M.
- Gagnon Advisors added most to Zuora, Inc. in Q3 2022, an estimated $3.58M increase.
- Gagnon Advisors's biggest Q3 2022 reduction was Pacira BioSciences, cutting an estimated $3.06M.
- Gagnon Advisors fully exited Direxion Daily 20+ Year Treasury Bear 3X ETF in Q3 2022, selling an estimated $4.67M.
- Gagnon Advisors's ten largest holdings make up 55% of its $154M portfolio in Q3 2022.
- Gagnon Advisors opened 1 new position and closed 2 in Q3 2022.
- Gagnon Advisors's portfolio value fell 6.5% quarter-over-quarter to $154M.
Based on Gagnon Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.